Skip to content

13th International Symposium on Mutation in the Genome: detection, genome sequencing & interpretation

Monday, 27 April 2015 to Thursday, 30 April 2015 from 10:30 AM - 1:00 PM

Holiday Inn Leiden, Netherlands


By attending this important event your company will:

  • Learn about the latest forthcoming technologies

  • Gain immediate feedback about your products

  • Share knowledge

  • Engage delegates in a relaxed environment & generate new sales leads

  • Access networking functions

  • Raise your profile and show your products to key decision makers

We are offering companies a number of opportunities where they can showcase their products and services to this specialist target group.

A company lecture within the meeting program for example allows you to disseminate your information to the entire audience. As sponsored lectures are extremely limited, priority is given to those companies who secure their place earlier.

Previous exhibitors will agree that this is a great networking meeting.

Who will attend?

  • Molecular geneticists from diagnostic labs
  • Molecular geneticists from research labs
  • Clinical pathologists
  • Cytogeneticists
  • Clinicians
  • & more


Opportunities for:

  • Trade displays
  • Company Lecture within the programme (limited)
  • Exclusive sponsorship of name badges/lanyards (one only)
  • Advertising in the programme booklet (limited)
  • Satchel Inserts
  • Sponsored Poster Prizes (one student and one researcher)
  • Combination packages to suit you
  • other to be discussed

To Discuss the Possibilities and Receive a detailed Sponsorship & Exhibitor's Prospectus please contact the Secretariat:

  • Ms Rania Horaitis


BioNano Genomics

Bionano Genomics’s Systems use the patented NanoChannel arrays located on proprietary chips to linearize intact DNA for direct imaging and de novo assembly, providing the long-range genomic information required for high-resolution discovery of structural variations. Bionano next-generation mapping (NGM) enables researchers to generate the highest-quality genome assemblies available today.
Leiden Genome Technology Center

The LGTC is an internal facility of the Center for Human and Clinical Genetics and the Leiden University Medical Center (LUMC). 

The LGTC has state-of-the-art technology to perform (high-throughput) genomics and transcriptomics analysis. In general, technology is available from two or more suppliers giving the possibility to make the best choice based on the combination of performance and cost. The LGTC focusses on innovation and technology development, to make things possible, not on production. Some platforms available are quite unique world-wide, incl. an Array-on-Demand system from FlexGen, nanoliter PCR from Fluidigm and a single molecule sequencing system from Pacific Biosciences.


MRC Holland
MRC-Holland logo 2009 v1.2.jpg

Amsterdam-based MRC-HOLLAND is the inventor and owner of the Multiplex Ligation-dependent Probe Amplification (MLPA) technology, a method used to detect copy number changes in both genomic DNA and tumours. MLPA® has rapidly established its reputation as a trustworthy and efficient method. Hundreds of publications about the technique have appeared since its introduction in 2002, and MLPA® is used in hundreds of laboratories worldwide. MRC-Holland is still actively developing new techniques, including MLPA for Next Gen Sequencing.

Phenosystems develops user-friendly software since 2002. Our software suite for molecular diagnostics comprises: GensearchNGS dedicated to mutation detection and interpretation on data from gene panels, Whole Exomes and Whole Genome; Gensearch for capillary DNA sequencing, GensearchGT Genotyping, GensearchHIV. Major features are high specificity and sensitivity, advanced tools to support variant interpretation (frameshifts, splice prediction, connection to LSDBs and to Café All have been developed together with leading diagnostics laboratories in Europe, packing powerful tools in an extremely user friendly interface.

Contact email:


Genome Diagnostics Nijmegen
5feb2013_optie01b (2).jpg

Genome Diagnostics Nijmegen is an ISO 15189:2012 certified laboratory, which provides high quality and up to date diagnostics of genetic disorders for patients and their families. The laboratory is equipped with the latest technologies to perform various types of diagnostic services. In all the diagnostic services offered, a full diagnostic interpretation of clinically relevant variants is included. The laboratory has over 130 coworkers and performs >25.000 tests and >4000 diagnostic exomes each year. Genome Diagnostics Nijmegen is part of the Department of Human Genetics of the Radboud university medical center and is based in the Netherlands. For information;


The Human Variome Project
HVP 2011 Logo.jpg

The Human Variome Project is an international consortium of individuals who are working towards reducing the burden of genetic disease. The aim of the Human Variome Project is to ensure that all information on genetic variation can be collected, curated, interpreted and shared freely and openly with the world.

In Kind

City of Leiden
In Kind

This historic city will captivate you with its charm, its elegance, its friendliness and its hidden treasures. A visit to Leiden can be an enriching experience; it will stimulate your curiosity and invite you to take a look into its illustrious past, to enjoy its fascinating present and to look towards its promising future.
Human Genome Variation
In Kind

As a new online, open access journal from Nature Publishing Group and the Japan Society of Human Genetics, Human Genome Variation provides articles, reports, and database on variation and variability in the human genome for research community.
Learn more about the journal at
RD - Connect
In Kind


RD-Connect is a global infrastructure project funded by the European Union that is developing an integrated research platform to bring together rare disease omics data with clinical and phenotypic data and information on biosample availability. The central RD-Connect platform enables rare disease researchers to access datasets from multiple rare disease omics projects and to perform online analysis of genomic data with a range of bioinformatics tools.
Royal Society Publishing
In Kind

Open Biology is an online, fully open access journal. It publishes articles covering biology at the molecular and cellular level.